Principal, Tech and Consulting
Managing Principal, BioTeknica
Partner, Global Regulatory, Hogan Lovells
This webinar explores how effective quality planning and preparation can enhance regulatory compliance for Pharma and Medtech companies. It covers the risks of receiving an FDA 483 or a Notified Body citation and highlights proactive steps like gap assessments and follow-up sessions to identify potential issues. Rather than relying solely on mock inspections, the session emphasizes strategic risk mitigation and expert preparedness to ensure compliance success.
Navigate the challenge of compliance, and its vital association with quality
